The Metastatic Breast Cancer Preceptorship is a comprehensive programme for Indian practitioners that include scientific presentations, interactive case studies and discussions. This meeting is designed to allow clinicians and young oncologists to stay up-to-date and assimilate new information into daily clinical practice. Spearheaded by an esteemed faculty, the programme provides a platform for clinicians to:
Program Director:Dr D. C. Doval (+91-11-47022252)
Program Coordinator: Dr Chaturbhuj Agrawal (+91-9810354544)
Logistics Coordinator: Mr. Purushottam (+91-9873608440)
Logistics Coordinator: Mr. Manoj Chauhan (+91-9873722247)
| Day 1 : 2nd February, 2019 | |||
| S. No. | Time | Session Topic | Speaker / Facilitator |
| 1 | 17:00-17:20 | Registration | |
| 2 | 17:20-17:30 | Welcome and opening remarks | Dr. D. C. Doval |
| 3 | 17:30-17:50 | The evolving treatment landscape of mBC: The past, present and future | Dr. Vineet Talwar |
| 4 | 17:50-18:10 | Research translation into clinic: Targetable pathways in mBC | Dr. Peush Bajpai |
| 5 | 18:10-18:30 | Tea break | |
| 6 | 18:30-19:30 | Meet the multidisciplinary mBC team at RGCI: How we work together
Facilitator : Dr. Chaturbhuj Agrawal |
Multidisciplinary mBC team Dr. Avinash Rao Dr. Anurag Mehta Dr. Rajeev Kumar Dr. Kumardeep Dutta Dr. Kundan Chufal Dr. Harsha Agarwal |
| 7 | 19:30-19:45 | Ongoing research in the field of breast cancer: RGCI | Dr. D. C. Doval |
| 8 | 19:45-20:00 | Summary of the day and close | Dr. D. C. Doval |
| 9 | 20:00 – onwards | Dinner | |
| Day 2 : 3rd February, 2019 | |||||||||||||||||||
| S. No. | Time | Session topic | Speaker / Facilitator | ||||||||||||||||
| Perspectives in HR+ HER2- mBC | |||||||||||||||||||
| 1 | 9:00-9:10 | Opening remarks | Dr. D. C. Doval | ||||||||||||||||
| 2 | 9:10-9:30 | CDK 4/6 inhibitors in breast cancer: what the existing trials revealed? | Dr. Kumardeep Dutta | ||||||||||||||||
| 3 | 9:30-9:45 | Global real world evidence with Palbociclib: Is it really practice changing? | Dr. Meenu Walia | ||||||||||||||||
| 4 | 9:45-10:00 | Real world evidence with Palbociclib: Experience in Indian patients | Dr. Chaturbhuj Agrawal | ||||||||||||||||
| 5 | 10:00-10:20 | CDK 4/6 inhibitors in breast cancer: what the future looks like | Dr. Chandragouda D. | ||||||||||||||||
| 6 | 10:20-10:40 | Optimal sequencing of available treatment options in the HR+/Her2Neu negative mBC | Dr. P. Suresh | ||||||||||||||||
| 7 | 10:40-11:00 | Panel discussion:The CDK4/6 inhibitors conundrum: How do I choose and which should I use?
Moderator: Dr. Ullas Batra |
Dr. Meenu Walia Dr. Chandragouda D. Dr. Kumardeep Dutta Dr. P. Suresh Dr. Rajat Bajaj Dr. Samit Purohit |
||||||||||||||||
| 8 | 11:00-11:20 | Tea break | |||||||||||||||||
| 9 | 11:20-12:30 | Experience across different mBC patient population: Case Discussion
|
|||||||||||||||||
| Perspectives in metastatic TNBC and HER2+ mBC | |||||||||||||||||||
| 10 | 12:30-12:50 | The role of Molecular Testing in breast cancer: How far we come? | Dr. Moushami Suryavanshi | ||||||||||||||||
| 11 | 12:50-13:10 | Optimizing outcomes in HER2+ mBC: Emerging evidence and practice strategies | Dr. Sameer Khatri | ||||||||||||||||
| 12 | 13:10-13:25 | What progress have we made in metastatic TNBC? | Dr. Sumit Goyal | ||||||||||||||||
| 13 | 13:25-13:45 | Panel discussion : The changing face of TNBC and HER2+ metastatic breast cancer Moderator: Dr. Randeep Singh |
Dr. Sumit Goyal Dr. Pankaj Goyal Dr. Varun Goel Dr. Mansi Sharma Dr. A. P. Dubey Dr. Abhishek Yadav |
||||||||||||||||
| 14 | 13:45-14:00 | Summary and Close | Dr. D. C. Doval | ||||||||||||||||
| 15 | 14:00-Onwards | Lunch and Departure | |||||||||||||||||
As a society, RGCIRC is looking forward to get support from generous people
Read More
It is a fact that there are absolutely no substitutes to replace human bloo...
Read More
Volunteers play an important role in today’s hospitals. They help the hos...
Read MoreRajiv Gandhi Cancer Institute & Research Centre is today counted amongst Asia’s premier exclusive cancer centres that offer unique advantage of cutting edge technology, put to use by renowned super specialists. This potent combination of man and machine ensures world-class cancer care to not only patients from India, but also from the neighboring SAARC countries and others.
D - 18, Sector - 5, Rohini, Delhi - 110085 | +91-11-47022222 OPD Timings: 09:00 am to 05:00 pm (All weekdays except Sunday and Holiday) Emergency Services: 24x7 All weekdays
Mahendra Kumar Jain Marg, Niti Bagh, New Delhi - 110049 | Tel: +91-11-45822222 / 2200 OPD Timings: 09:00 am to 05:00 pm (All Weekdays except Sunday and Holiday) Emergency Services: 24x7 All Weekdays
DONATE